Affinity Asset Advisors »

Syros Pharmaceuticals shares owned by Affinity Asset Advisors

Quarter-by-quarter ownership of Syros Pharmaceuticals (SYRS) shares owned by Affinity Asset Advisors from 13F filings

Historical chart of Affinity Asset Advisors investment in Syros Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Syros Pharmaceuticals held by Affinity Asset Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Syros Pharmaceuticals by Affinity Asset Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $2.7M 1.2M 2.15

More positions owned by Affinity Asset Advisors

Xenon Pharmaceuticals (XENE)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Cassava Sciences Put Option (SAVA)
Apogee Therapeutics (APGE)
Nuvalent Inc-a (NUVL)
Arcellx Common Stock (ACLX)
Alkermes SHS (ALKS)
Madrigal Pharmaceuticals (MDGL)
Crinetics Pharmaceuticals In (CRNX)
Nurix Therapeutics (NRIX)
Vera Therapeutics Cl A (VERA)
Verona Pharma Sponsored Ads (VRNA)
Autolus Therapeutics Spon Ads (AUTL)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Inozyme Pharma (INZY)

View all positions for Affinity Asset Advisors

Top funds holding Syros Pharmaceuticals

Bain Capital Life Sciences Investors
Siren
Samsara BioCapital
Point72 Asset Management
Flagship Ventures Management
Affinity Asset Advisors
Avidity Partners Management
Vanguard Group
Deep Track Capital
Opaleye Management
Blue Owl Capital Holdings
Kennedy Capital Management
ExodusPoint Capital Management
Goldman Sachs Group
BlackRock

View all funds holding Syros Pharmaceuticals